N/A N=1,328 METEOR Think NIV Pilot
Acute Respiratory Failure
Primary: Number of ICU Team Members (Learners) Who Received Education — 22; 31; 12 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=65 Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe
Chorioretinal Vascular Disease
Primary: Number of Aflibercept Injections Successfully Administered Utilizing the Prefilled Syringe (PFS) — 35; 29 Injections
Phase 3 N=91 A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)
Posttraumatic Stress Disorder
Primary: Change From Baseline to Primary Endpoint in Clinician Administered PTSD Scale for DSM-V (CAPS-5) — -24.5; -12.64 score on a scale
N/A N=156 OptiMesh® for Lumbar Interbody Fusion Trial (OLIF)
Degeneration of Lumbar Intervertebral Disc
Primary: Mean Change in Low Back Pain Score at 24-months Compared to Pre-op — -4.0; -4.0 units on a scale
N/A N=20 A Standard Music Program Compared to an Optimized Music Program
Hearing Loss
Primary: Preference Rating — 14; 3; 3 Participants
Phase 2 N=231 Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
Acute Episode of Overt Hepatic Encephalopathy · Hepatic Encephalopathy
Primary: Percentage of Participants in Each HE Stage — 11; 6; 30; 40 percentage of participants
N/A N=16 Functional Research of Emulsifiers in Humans
Healthy
Primary: Distance of Nearest Bacteria to the Epithelium — 17.06776; 14.09342 µm
N/A N=66 Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study
PAD · Vascular Calcification
Primary: Device Success — 42; 39 Drug Coated Balloons
Phase 4 N=35 Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus Infection
Hepatitis C Virus
Primary: Ribavirin AUC-12 Variability — 34425; 40903 ng*hr/mL
Phase 2 N=14 Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
Posttraumatic Stress Disorder
Primary: Change From Baseline to Primary Endpoint in Clinician Administered PTSD Scale for DSM-IV (CAPS-IV) — -15.6; 3.3 score on a scale
N/A N=132 AirSeal®Insufflation Trocar/CO2 Absorption Study
Gynecologic Diseases
Primary: Average Carbon Dioxide (CO2) Absorption During Gynecologic Laparoscopy Using the AirSeal® Versus Standard Trocars at Intra-abdominal Pressures of 10 mmHg — 3.96; 4.05…
N/A N=12 PEPNS System Feasibility Study
Ventilator Induced Diaphragmatic Dysfunction (VIDD)
Primary: Percent Capture of Left and/or Right Phrenic Nerve — 96.56 percentage of phernic nerve capture — p=0.0125
Phase 2 N=18 A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
Osteosarcoma
Primary: Response Rate — 0 percentage of participants
Phase 3 N=507 Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer
Refractory Metastatic Gastric Cancer
Primary: Overall Survival (OS) — 5.7; 3.6 months — p=0.0003
Phase 2 N=80 SI-613 Study for Knee Osteoarthritis
Osteoarthritis, Knee
Primary: Change From Baseline in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscore Over 12 Weeks — -29.9; -27.0 score on a scale — p=0.5453